Primary Achalasia : POEM Vs Heller's Myotomy AMOL BAPAYE MD (MS ), FAS GE

Similar documents
Management of the Difficult Patient with Type 3 Achalasia. Steven R. DeMeester Professor and Clinical Scholar Department of Surgery

Achalasia: Classic View

Description. Section: Medicine Effective Date: January 15, 2015 Subsection: Original Policy Date: December 6, 2013 Subject: Page: 1 of 7

POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT VARIATIONS DISCLAIMER CODING INFORMATION REFERENCES POLICY HISTORY

Treating Achalasia. When to consider surgery and New options for therapy

Duke Masters of Minimally Invasive Thoracic Surgery Orlando, FL. September 17, Session VI: Minimally Invasive Thoracic Surgery: Miscellaneous

A Novel Endoscopic Treatment for Achalasia Is the POEM mightier than the sword?

Per-oral Endoscopic Myotomy

Peroral Endoscopic Myotomy for Treatment of Esophageal Achalasia

MP Peroral Endoscopic Myotomy for Treatment of Esophageal Achalasia

Achalasia: Inject, Dilate, or Surgery?

Comparison of the Outcomes of Peroral Endoscopic Myotomy for Achalasia According to Manometric Subtype

Peroral endoscopic myotomy (POEM) for treating esophageal motility disorders. Citation Annals of Translational Medicine, 2017, v. 5 n. 8, p.

How I Do It? Per-oral Endoscopic Myotomy (POEM) Ping-hong ZHOU, MD. Endoscopy Center, Zhongshan Hospital Fudan University, Shanghai, China

34th Annual Toronto Thoracic Surgery Refresher Course

Diagnosis and Management of Achalasia: Past, Present, & Future

4/24/2015. History of Reflux Surgery. Recent Innovations in the Surgical Treatment of Reflux

Efficacy of peroral endoscopic myotomy compared with other invasive treatment options for the different esophageal motor disorders

Achalasia Current Diagnosis and Management

Marc F. Catalano, MD, FACG, FACP, AGAF, FASGE Professor of Medicine Department of Internal Medicine Division of Gastroenterology and Hepatology The

Gastroesophageal Reflux Disease, Paraesophageal Hernias &

Surgical Treatment for Achalasia

ACHALASIA ACHALASIA. Current Management of Achalasia

Per-oral endoscopic myotomy for achalasia cardia: outcomes in over 400 consecutive patients

High Resolution Manometry: A new perspective on esophageal motility disorders. Chris Andrews & Bill Paterson

SAGES guidelines for the surgical treatment of esophageal achalasia

What is New in Esophageal Motility Disorders

Surgery for achalasia is an anachronism. John C. Dugal Jr. MD

doi: /den.12495

Peroral Endoscopic Myotomy for the Treatment of Achalasia in a 10-Year-Old Male Patient

A prospective analysis of GERD after POEM on anterior myotomy

Current status of achalasia management: a review on diagnosis and treatment

MEDICAL POLICY SUBJECT: MAGNETIC ESOPHAGEAL RING/ MAGNETIC SPHINCTER AUGMENTATION FOR THE TREATMENT OF GASTROESOPHAGEAL REFLUX DISEASE (GERD)

SAGES Guidelines for the Surgical Treatment of Esophageal Achalasia

Ten Initial Cases of Peroral Endoscopic Myotomy for Treatment of Esophageal Motility Disorders at Okayama University Hospital

ORIGINAL ARTICLE UNCORRECTED-IN-PROCESS

LAPAROSCOPIC HELLER MYOTOMY WITH FUNDOPLICATION FOR ACHALASIA

Per-oral endoscopic myotomy (POEM): a new endoscopic treatment for achalasia

Achalasia is diagnosed by showing dysfunction of lower

Combined Experience of Two European Centers

Service Line: Rapid Response Service Version: 1.0 Publication Date: January 15, 2018 Report Length: 36 Pages

Magnetic Esophageal Sphincter Augmentation to Treat Gastroesophageal Reflux Disease (GERD)

Quality of Life Comparing Dor and Toupet After Heller Myotomy for Achalasia

JNM Journal of Neurogastroenterology and Motility

Novel Approaches for Managing Reflux. Marcus Reddy Consultant General and Upper GI surgeon

Health-related quality of life and physiological measurements in achalasia

Review Article Surgical Treatment for Achalasia of the Esophagus: Laparoscopic Heller Myotomy

Peroral Endoscopic Myotomy for Treatment of Achalasia: Initial Results of a Korean Study

The Influence of Operation Technique on Long-Term Results of Achalasia Treatment

Review Article Peroral Endoscopic Myotomy for the Treatment of Achalasia: An Analysis

UC Irvine UC Irvine Previously Published Works

Laparoscopic Heller Myotomy for Achalasia: Changing Trend Toward True Day-Case Procedure

The current state of per oral endoscopic myotomy for achalasia

Peroral endoscopic myotomy is effective and safe in non-achalasia esophageal motility disorders: an international multicenter study

Title: endoscopic myotomy (POEM): a new. new endoscopic treatment for achalasia

What s New in the Management of Esophageal Disease

L ANELLO MAGNETICO NELLA TERAPIA DEL REFLUSSO

MINIMALLY INVASIVE ESOPHAGECTOMY FOR CANCER: where do we stand?

Joel A. Ricci MD SUNY Downstate Medical Center Lutheran Medical Center Department of Surgery June 26, 2009

Achalasia is a rare motility disorder of the esophagus

Magnetic Esophageal Sphincter Augmentation to Treat Gastroesophageal Reflux Disease (GERD)

A CURIOUS CASE OF HYPERTENSIVE LES. Erez Hasnis Department of Gastroenterology Rambam Health Care Campus

Oesophageal Disorders

Steven Frachtman, M.D. Division of Gastroenterology/Hepatology August 18, 2011

Peroral endoscopic myotomy for achalasia

잭해머식도를경구내시경근절개술로치료한 1 예

Gastroesophageal reflux disease Principles of GERD treatment Treatment of reflux diseases GERD

Options for Gastroesophageal Reflux: Endoluminal. W. Scott Melvin, M.D. Montefiore Medical System and the Albert Einstein School of Medicine

Surgical Evaluation for Benign Esophageal Disease. Kimberly Howard, PA-C, MHS Duke University Medical Center April 7, 2018

Long-term outcomes of balloon dilation versus botulinum toxin injection in patients with primary achalasia

Achalasia is a rare disorder of the esophagus that results

The impact of flexible endoscopy in esophageal surgery

Endoscopic Submucosal Dissection ESD

ORIGINAL ARTICLE LAPAROSCOPIC HELLER S CARDIOMYOTOMY FOR ACHALASIA CARDIA WITH AND WITHOUT DOR FUNDOPLICATION OUR INITIAL EXPERIENCE.

Achalasia is a primary esophageal motility disorder of unknown

Findings of Esophagography for 25 Patients After Peroral Endoscopic Myotomy for Achalasia

Barrett s Esophagus: What to Do for No Dysplasia, LGD, and HGD?

A Multidisciplinary Approach to Esophageal Dysphagia: Role of the SLP. Darlene Graner, M.A., CCC-SLP, BRS-S Sharon Burton, M.D.

Perspective on Peroral Endoscopic Myotomy for Achalasia: Zhongshan Experience

The therapeutic results after laparoscopic hellers myotomy and partial fundoplication for achalasia

The impact of fibrin glue in the prevention of failure after Nissen fundoplication

Endoscopic vs Surgical Therapies for GERD: Is it Time to Put down the Scalpel?

Esophageal Manometry. John M. Wo, M.D. October 1, 2009

Achalasia is a rare disease with an annual incidence estimated REVIEWS. Erroneous Diagnosis of Gastroesophageal Reflux Disease in Achalasia

Esophageal Motility Disorders. Disclosures

Achalasia is an immune-mediated destruction of the

Magnetic Esophageal Ring to Treat Gastroesophageal Reflux Disease (GERD)

Magnetic Esophageal Ring to Treat Gastroesophageal Reflux Disease (GERD)

Minimally Invasive Esophagectomy- Valuable. Jayer Chung, MD University of Colorado Health Sciences Center December 11, 2006

Barrett s Esophagus. Abdul Sami Khan, M.D. Gastroenterologist Aurora Healthcare Burlington, Elkhorn, Lake Geneva, WI

pissn: eissn: Journal of Neurogastroenterology and Motility

Chicago Classification of Esophageal Motility Disorders: Lessons Learned

Clinical trial: 24-h ph monitoring patterns and clinical response after achalasia treatment with pneumatic dilation or laparoscopic Heller myotomy

Symptomatic outcome following laparoscopic anterior 180 partial fundoplication: Our initial experience

Disclosures. GI Motility Disorders. Gastrointestinal Motility Disorders & Irritable Bowel Syndrome

Robotics in General Surgery. Objectives

Refractory GERD : case presentation and discussion

History. Prevalence at Endoscopy. Prevalence and Reflux Sx. Prevalence at Endoscopy. Barrett s Esophagus: Controversy and Management

Minimally Invasive Esophagectomy

Supplementary appendix

Transcription:

Primary Achalasia : POEM Vs Heller's Myotomy AMOL BAPAYE MD (MS ), FAS GE SHIVANAND DESAI CENTER FOR DIG EST IVE DISOR DERS DEENANAT H MANGESHKAR HOSPITAL & R ESEAR C H C ENTER, PUNE, INDIA

What is Achalasia Cardia? Benign progressive disorder characterized by loss of esophageal motility & non relaxation of LES on wet swallows Therapy aims at Disruption / relaxation of circular muscle fibers at LES No method devised to improve esophageal body motility Therapeutic options Pharmacotherapy Endoscopic balloon dilatation Endoscopic Botox injection Laparoscopic Heller s myotomy (LHM) Per-oral endoscopic myotomy (POEM)

What Is POEM?

Pre POEM Post POEM 1 Minute 2 Minute

Is POEM effective? POEM : A Series of 500 Patients 3 yr or more follow up 61 pts Eckardt score - 1 Post-operative LES - 11.7 mm Hg Overall success rate was - 88.5% Sigmoid Esophagus Failed LHM/ Endoscopic Inoue H et al. 2015

POEM Efficacy Continent N Mean Age Mean Length (cm) Eckardt Score Pre/Post LES pressure Pre/Post (mmhg) Efficacy ASIA 374 45 13.5 6.33/1.19 32.5/4.9 97.9% NORTH AMERICA 107 50.4 9.1 7.4/0.3 38.6/14.3 95.3% EUROPE 128 43.5 12.4 7.1/1.0 34.1/12.5 88.6% Weighted results for published series Mean follow up of 6 months (1-13 months) Stavropoulos et al, Ther Adv Gastroenterol 2013

Is POEM effective? POEM efficacy >90%

Long-term outcomes of per-oral endoscopic myotomy in achalasia patients with a minimum follow-up of 2 years: an international multicenter study Saowanee Ngamruengphong 1, Haruhiro Inoue 2, Philip Chiu 3, Hon-Chi Yip 3, Amol Bapaye 4, Michael Ujiki 5, et al. GIE 2016 (accepted for publication) N = 205, prior therapy = 81 (39.5%) Median follow up = 31 months (IQR 26 38) Clinical success = 98% (185/189), 98% (142/144), & 91% (187/205) at 6, 12 & 24-months 185 patients with clinical response @ 6-months recurrent symptoms @ 2- years = 11 (6%) Prior PBD associated with long-term Conclusions Rx failure (OR, 3.41; 95% CI, 1.25 9.23) POEM Procedure is safe and related provides AE = 8.2% high initial clinical success and excellent long-term Abnormal esophageal acid exposure outcomes and GERD = 37.5% and 18%

Is LHM Ideal? Safety and outcomes of laparoscopic reoperation for achalasia Recurrence of achalasia after LHM 20% Commonest cause is incomplete myotomy Zaninotto G Ann Surg 2002; 235: 186 192 LHM although a gold standard for many years, IS NOT the IDEAL procedure for achalasia

Is LHM Ideal? National outcomes of laparoscopic LHM: Operative complications and risk factors for adverse events. Overall complications 59 / 1237 (4.8%) major 2.8%, deaths 4 Intra-operative mucosal injury 4% (not recorded as complication) Readmissions 3.1%, reoperations 2.3% LOS 2.8d +/- 5.5d Advanced age, co-morbid illness associated with increased operating time, complications & LOS Ross SW Surgical endoscopy 2015

Is LHM Ideal? Reasons and prevalence of reoperations after esophagomyotomy for achalasia. 18% re-interventions due to failure or complications 9% repeat operations due to incomplete myotomy Conclusions Early reoperations due to technical errors (mucosal injury) Late reoperations due to recurrence (incomplete myotomy) Li J Surg Laparosc Endosc Percutan Tech. 2012 Oct;22(5):392-5.

POEM Vs LHM Seven Studies POEM (n) LHM (n) Type Bhayani et al, 2014 37 64 Prospective Vigneswaran et al, 2014 5 3 Retrospective Hungness et al, 2014 18 55 Retrospective Tietelbaum et al, 2013 12 17 Prospective Ujiki et al, 2013 18 21 Prospective Kumagai et al, 2015 42 41 Prospective Chan et al, 2015 33 23 Retrospective Last two studies have not been included in any of the published meta-analyses

POEM Vs LHM Two Abstracts POEM n LHM n Renteln V et al, 2013 70 110 Type of Comparison Prospective Kumbhari et al, 2015 52 52 Retrospective Von Renteln D, Fockens P et al. Gastrointest. Endosc. 2013; 77 (Supp 5): AB122. Kumbhari V et al. Gastrointes. Endosc. 2015; 81 (Supp 5): AB492.

Studies Comparing POEM Vs LHM Efficacy Complications a. Operative time b. Hospital stay Follow up Bhayani et al Equal Both Less in POEM 6 months Vigneswaran et al Equal - 5 months Hungness et al Equal a. Less in POEM b. Similar 6 months Tietelbaum et al Equal improvement in EGJ distensibility (FLIP) Ujiki et al Equal Equal in both 116/ 164 days

Studies Comparing POEM Vs LHM Kumagai et al Equal Equal Efficacy Efficacy Complications All Studies a.operative time b.hospital stay a.less in POEM b.equal Chan et al Differences Equal a. Less in POEM b. Equal Operative time Renteln V et al* Equal a. - - Pain/ Blood loss b. - Kumbhari et al** Similar adverse events - Hospital stay Equal a. Less in POEM - Early resumption b. to work Equal Follow up 3 months 6 months 3 months 4.3 months - Less cost *POEM - lower 3 month Eckhardt scores (1 vs. 1.4,p=0.05), lower post-op LESP (9 vs.12 mmhg, p=0.01) **POEM - less cost ($14,481 vs. $17,782)

Meta-analyses - POEM Vs LHM Four Meta-analyses Studies Total (Comparative) Talukdar et al, 2014 19 (5) Patel et al, 2015 22 (3) Wei et al, 2015 4 Zhang et al, 2016 4

Meta-analyses - POEM Vs LHM Meta-analysis Main Outcome Studies Total (Comparative) Talukdar et al, 2014 All Meta-analyses Equal efficacy, pain, reflux, adverse events 19 (5) Patel et al, 2015 Equal Efficacy Similar adverse events, perforation, operative time Similar adverse events 22 (3) Wei et al, 2015 Comparable complications and recurrence 4 Differences Operative time Zhang et al, 2016 Equal efficacy, safety, stay and operation time 4

Redo LHM compared to primary LHM More complications due to scarring and fibrosis due to previous intervention Redo Heller: More conversion to open (up to 7%) Longer procedure time Lower efficacy More postoperative complications: gastrointestinal perforations (1.5% to 20%), pneumothorax (1.9% to 6.7%), pulmonary complications (1.3% to 4% of patients) Wang L, Li YM, World J Gastroenterol 2008; 14:7122e7126 Rosemurgy AS, J Am Coll Surg. 2010 May;210(5):637 45, 645 7 Lynch KL, Am J Gastroenterol, 107(12):1817-25 James, D. R. Minim Invasive Ther Allied Technol 2012, 21 (3), 161-7

Author (year) Type Sample size Control/Cohorts Previous intervention Follow up (months) Outcome Onimaru (2013) Prospective 10 (11)/ 315 (total) Sharata (2013) Retrospective I: 12 NI: 28 All post Heller PBD failure Bo: 10 PBD: 2 Zhou (2013) Prospective 12 All failed Heller 10.4 ± 3.1 Vigneswaran (2014) Ornstein (2014) Retrospective, Prospective database 8 (all post Heller) (POEM:5 Heller:3) I:16 NI:24 Ling (2014) Prospective PBD: 21 NI: 30 All post Heller POEM: Bo 2, PBD 4, Fundopl 3 Heller: Bo 1, PBD 2, Fundopl 2 BO 9, PBD 9, HM 3, Fundopl2 All PBD failure 18.3 (3-13) Feasibility Procedure time Difficulty 6 Efficacy: Symptom relief Eckardt Score improvement 5 LES pressure reduction Complications GERD QOL Meds used prior & after POEM 10 POEM post intervention is effective in reduction of symptoms, dysphagia score, LES pressure with acceptable complication rate in short/medium follow up Comparable to data when performed without prior intervention POEM in post intervention setting is associated with QOL improvement 1 yr (I)/1.2+0.2 yr (NI)

Advantages of POEM over LHM 1. Direct visual recognition of the submucosal layer, less perforations 2. POEM is submucosal, doesn t alter surrounding anatomy; possible less reflux, less severe reflux; further treatment options are safer 3. Less chances of fusion of the myotomy line in view of lateral dissection post POEM

Comparative Evaluation of Per Oral Endoscopic Myotomy (POEM) for the Treatment of Achalasia in Patients With Failed Heller Myotomy vs Patients Without a History of Surgical Myotomy: A Multicenter Retrospective Cohort Study Saowanee Ngamruengphong, Haruhiro Inoue, Michael Ujiki, Amol Bapaye, Pankaj N. Desai, Thierry Ponchon, et al GIE 2016 (Abstract) N = 181 (91 prior HM, 90 controls), 11 centers (4 US, 4 Europe, 3 Asia) Controls matched for age, achalasia subtype & Eckhardt scores Clinical response defined as post POEM Eckhardt scores <= 3 Technical success, clinical success & AE s compared between two groups Mean follow up = 8.5 months (IQR 3.2 14.7) Technical success comparable 89/91 (98%) vs 100% (p=0.49) Procedure times similar Adverse events comparable 7 (8%) vs 12 (13%) (p=0.23)

Comparative Evaluation of Per Oral Endoscopic Myotomy (POEM) for the Treatment of Achalasia in Patients With Failed Heller Myotomy vs Patients Without a History of Surgical Myotomy: A Multicenter Retrospective Cohort Study Saowanee Ngamruengphong, Haruhiro Inoue, Michael Ujiki, Amol Bapaye, Pankaj N. Desai, Thierry Ponchon, et al GIE 2016 (Abstract) Clinical response significantly lower in HM group 80% vs 94% (p=0.02) Mean post POEM Eckhardt scores higher in HM group - 2.09 +/- 2.5 vs 1.08 +/- 1.2 (p=0.002) Univariate analysis prior HM (OR 3.54, p 0.02) & prior PD (OR 3.36, p 0.01) were significantly associated with clinical failure Multivariate analysis prior HM (adjusted OR 2.91, p 0.05) was marginally associated with clinical failure after Conclusions POEM Although rate of clinical success in patients with prior HM is lower than those without, safety profile of POEM is comparable in both groups

Type III Achalasia/ SED s: Tailor-made myotomy according to requirement / indication Long segment LES Spastic contractions in lower third esophagus Rarest amongst all AC types Most difficult to treat Part of SED s DES, Jackhammer esophagus

Results of Rx for AC according to type

POEM for Type III AC Khashab et al GIE 2015 The only multicenter retrospective study N = 73, Includes all SED s Type III AC = 54 DES = 9 Jackhammer = 10 Outcome measure Eckhardt score < / = 3 Mean length of myotomy 16cm (6 26) Duration of procedure 118min (43 345)

POEM for Type III AC Khashab et al GIE 2015 Success = 93% (overall) Type III AC = 96.3% DES = 100% Jackhammer = 70% Relief of chest pain 87% Reduction in Eckhardt score Overall 6.73 to 1.13 (p < 0.01) Type III AC 6.4 to 0.86 (p < 0.01) AE = 8 / 73 (11%)

POEM vs. LHM for Type III AC Kumbhari et al EIO 2015 The only retrospective comparative study Multicenter N = 75 POEM 49 (multicenter) LHM + Dor / Toupet 26 (single center) Primary outcome symptom improvement & decrease in Eckhardt score 1 Secondary outcomes myotomy length, procedure duration, hospital stay, rate of AE

POEM vs. LHM for Type III AC Kumbhari et al EIO 2015 Clinical response 98 vs. 80.8% (p < 0.01) Mean procedure time 102 vs. 264min (p < 0.01) Myotomy length = 16 vs. 8cm (p < 0.01) AE = 6 vs. 27% (p < 0.01) Hospital stay = 3.3 vs. 3.2days (p = 0.68) Post procedure PPI = 38.8 vs. 46.1% (p = 0.7)

Sigmoid Achalasia POEM feasible, effective for sigmoid type (both S1 / S2) including advanced sigmoid achalasia (not amenable to LHM) Inoue Endoscopy 2010, Hu JW Surg endosc 2015, Eleftheriadis N Ann Gastroenterol 2014

POEM & GERD POEM has less or similar reflux / less severe reflux (12 35%) Chuah SK 2013 Cumulative Results of LHM Bhayani NH Annals of surgery 2014; 259: 1098-1103 Inoue H Japanese Journal of clinical medicine 2010; 68: 1749-1752 Bapaye et al J Gastroenterol Hepatol 2014 (Abstract)

Why GERD is a Problem in LHM: Hiatal dissection & post-op GERD Parameter Heller - Dor + Complete HD Heller - Dor + limited HD Heller only + limited HD P-value Median resting LES pressures Low High High < 0.001 Median acid exposure time High Low Low < 0.001 Abnormal De Meester @ 3-yrs 23.1% 8.5% 9.1% < 0.001 Prospective, randomized 3-yrs follow up 84 pts of LHM Conclusion Limited HD achieves better post op GERD control No Hiatal Dissection in POEM! Simic AP. J Gastrointest Surg 2010

Advantages of POEM: Summary

PD VS LHM Graded or on demand dilatation is equal to LHM in type I And Type II AC LHM better than Single dilatation PD VS POEM No comparative data

Individualized treatment PD LHM POEM TYPE I AC 63-65% 81% 91.4% TYPE II AC 90-93% 93-100% 93.6% TYPE III AC 33-40% 80-86% 98% Overall efficacy 44-84% 57-89.3% 80-97% Follow up > 5 years > 5 years 1-3 Years GER 4% 9-33% 15-30% Zaheer, Reddy DN, Ramchandani M, J Gastrointest Dig Syst 2016

Summary of available data LHM > Single Pneumatic dilatation LHM = Graded Dilatation (Type I, II) POEM = LHM POEM >= LHM (Type III, spastic disorders) POEM vs PD No literature

POEM Should it be the first line of treatment? Yes If I am in a institute where expertise is available If my patient is non compliant for repeated dilatation If patient desires minimally invasive & one time treatment If patient has type III achalasia No If patient has type II / type I achalasia & is willing for repeated dilatation (PBD) Severe sigmoidization Esophagectomy

Thank You!